Aarti Drugs Ltd (AARTIDRUGS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 657348, "name": "Aarti Drugs", "stock_name": "Aarti Drugs", "full_name": "Aarti Drugs Ltd", "name_url": "stocks-analysis/aarti-drugs", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "343.15", "chg": 5.55, "chgp": "1.64%", "dir": 1, "prev_price": "337.60", "mcapval": "3,126.00 Cr", "mcap": "Small Cap", "scripcode": 524348, "symbol": "AARTIDRUGS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE767A01016", "curr_date": "Mar 20", "curr_time": "", "bse_nse_vol": "1.06 lacs", "exc_status": "Active", "traded_date": "Mar 20, 2026", "traded_date_str": "2026 03 20", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-drugs-657348-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Aarti Drugs Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-strong-sell-3902715", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AartiDrugsLtd_mojoScore_3902715.png", "date": "2026-03-20 10:10:45", "description": "Aarti Drugs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Aarti Drugs Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-strong-sell-3878626", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AartiDrugsLtd_mojoScore_3878626.png", "date": "2026-03-09 10:10:56", "description": "Aarti Drugs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 February 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Why is Aarti Drugs Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aarti-drugs-ltd-fallingrising-3865725", "imagepath": "", "date": "2026-03-03 01:10:30", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been under pressure for several sessions, with a consecutive three-day decline resulting in a cumulative loss of 3.27%. On the day in question, Aarti Drugs opened sharply lower, down 6.63%, and touched an intraday low of ₹342.65, signalling strong selling interest. This underperformance extended beyond the single day, as the stock has lagged its sector by 2.35% and the broader Sensex index by a wider margin over the past month and year. Specifically, over the last month, the stock fell 6.74%, significantly worse than the Sensex’s 1.75% decline, while year-to-date losses stand at 13.17%, more than double the benchmark’s 5.85% fall.</p>\n<p>Technically, the stock is trading below all key moving averages—5-day, 20-day, 50-day..." }, { "title": "Aarti Drugs Ltd Opens with Significant Gap Down Amid Market Concerns", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-opens-with-significant-gap-down-amid-market-concerns-3865167", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AartiDrugsLtd_gapdown_3865167.png", "date": "2026-03-02 13:31:47", "description": "Aarti Drugs Ltd commenced trading today with a pronounced gap down, opening 6.63% lower at Rs 342.65, reflecting heightened market apprehensions following recent developments. The stock’s weak start underscores ongoing pressures within the Pharmaceuticals & Biotechnology sector, as it continues to underperform both its sector peers and the broader market indices." }, { "title": "Aarti Drugs Ltd Falls 1.52%: Technical Shifts and Financial Weakness Define the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-falls-152-technical-shifts-and-financial-weakness-define-the-week-3862525", "imagepath": "", "date": "2026-02-28 15:05:56", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Feb:</strong> Rating upgraded to Sell on technical improvement despite mixed financials</p>\n <p><strong>24 Feb:</strong> Technical momentum shifts amid bearish signals</p>\n <p><strong>26 Feb:</strong> Downgrade to Strong Sell amid weak financials and bearish technicals</p>\n <p><strong>27 Feb:</strong> Week closes at Rs.367.00, down 1.52%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.372.65</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class..." }, { "title": "Aarti Drugs Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3857411", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AartiDrugsLtd_mojoScore_3857411.png", "date": "2026-02-26 08:08:10", "description": "Aarti Drugs Ltd has been downgraded from a Sell to a Strong Sell rating as of 25 Feb 2026, reflecting deteriorating technical indicators and disappointing financial performance. The company’s Mojo Score has slipped to 28.0, signalling heightened caution for investors amid a bearish technical outlook, weakening profitability, and subdued valuation metrics despite some operational strengths." }, { "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Bearish Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-bearish-signals-3852104", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AartiDrugsLtd_technicaldot_3852104.png", "date": "2026-02-24 08:03:48", "description": "Aarti Drugs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a more pronounced bearish trend. Despite a marginal day decline of 0.23%, the stock’s technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signal increasing downside pressure. This comprehensive analysis explores the evolving technical landscape of Aarti Drugs Ltd, contextualising its performance against broader market benchmarks and sector dynamics." }, { "title": "Aarti Drugs Ltd Upgraded to Sell on Technical Improvement Despite Mixed Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-drugs-ltd-upgraded-to-sell-on-technical-improvement-despite-mixed-financials-3851063", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AartiDrugsLtd_mojoScore_3851063.png", "date": "2026-02-23 08:07:17", "description": "Aarti Drugs Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 February 2026, reflecting a nuanced shift in its technical outlook and valuation metrics despite ongoing financial challenges. The pharmaceutical company’s Mojo Score has improved to 34.0, signalling a cautious but more optimistic stance amid mixed performance across quality, valuation, financial trends, and technical indicators." }, { "title": "Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-amid-mixed-market-signals-3850712", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AartiDrugsLtd_technicaldot_3850712.png", "date": "2026-02-23 08:01:47", "description": "Aarti Drugs Ltd has experienced a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.22%, the stock’s broader technical signals and relative performance against the Sensex suggest cautious investor sentiment amid ongoing sector challenges." } ], "total": 676, "sid": "657348", "stock_news_url": "https://www.marketsmojo.com/news/aarti-drugs-657348" }, "announcements": [ { "details": "Disclosure under SEBI Takeover Regulations AARTIDRUGS : Seema Harshit Savla has submitted to the Exchange, vide letter dated November 21, 2019 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.", "source": "NSE", "caption": "Aarti Drugs Limited - Disclosure under SEBI Takeover Regulations", "datetime": "22-Nov-2019" }, { "details": "Aarti Drugs Limitedany namely Aarti Speciality Chemicals Limited CIN No: U24230MH2019PLC333306 on November 20, 2019.", "source": "NSE", "caption": "Aarti Drugs Limited - Acquisition", "datetime": "21-Nov-2019" }, { "details": "Disclosure under SEBI Takeover Regulations AARTIDRUGS : Seema Harshit Savla has submitted to the Exchange vide letter dated November 07, 2019 a copy of Disclosure as per Regulation 10(5) of SEBI (SAST) Regulation 2011", "source": "NSE", "caption": "Aarti Drugs Limited - Disclosure under SEBI Takeover Regulations", "datetime": "08-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Aarti Drugs Ltd has declared <strong>20%</strong> dividend, ex-date: 09 Feb 26", "dt": "2026-02-09", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Aarti Drugs Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 30 Sep 20", "dt": "2020-09-30", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

23 Feb: Rating upgraded to Sell on technical improvement despite mixed financials

24 Feb: Technical momentum shifts amid bearish signals

26 Feb: Downgrade to Strong Sell amid weak financials and bearish technicals

27 Feb: Week closes at Rs.367.00, down 1.52%

Week Open

Rs.372.65

Week Close

Read full news article

Aarti Drugs Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-02-26 08:08:10

Aarti Drugs Ltd has been downgraded from a Sell to a Strong Sell rating as of 25 Feb 2026, reflecting deteriorating technical indicators and disappointing financial performance. The company’s Mojo Score has slipped to 28.0, signalling heightened caution for investors amid a bearish technical outlook, weakening profitability, and subdued valuation metrics despite some operational strengths.

Read full news article

Aarti Drugs Ltd Technical Momentum Shifts Amid Bearish Signals

2026-02-24 08:03:48

Aarti Drugs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a more pronounced bearish trend. Despite a marginal day decline of 0.23%, the stock’s technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signal increasing downside pressure. This comprehensive analysis explores the evolving technical landscape of Aarti Drugs Ltd, contextualising its performance against broader market benchmarks and sector dynamics.

Read full news article

Aarti Drugs Ltd Upgraded to Sell on Technical Improvement Despite Mixed Financials

2026-02-23 08:07:17

Aarti Drugs Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 February 2026, reflecting a nuanced shift in its technical outlook and valuation metrics despite ongoing financial challenges. The pharmaceutical company’s Mojo Score has improved to 34.0, signalling a cautious but more optimistic stance amid mixed performance across quality, valuation, financial trends, and technical indicators.

Read full news article

Aarti Drugs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-23 08:01:47

Aarti Drugs Ltd has experienced a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.22%, the stock’s broader technical signals and relative performance against the Sensex suggest cautious investor sentiment amid ongoing sector challenges.

Read full news article